Xinliang Liu
Overview
Explore the profile of Xinliang Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Guo W, Song C, Liu X, Yu J, Ge Y
Materials (Basel)
. 2025 Mar;
18(5).
PMID: 40077151
A polydimethylsilosane/multiwalled carbon nanotube (PDMS/MWCNT) nanocomposite, as a tensile-strain-sensing material, was manufactured using a simple solution casting method. The percolation threshold, the relationship between the temperature and resistance, the tensile...
2.
Luo C, Liu X, Zheng Y, Dai X, Tang X, Zhang T, et al.
BMC Plant Biol
. 2024 Dec;
24(1):1217.
PMID: 39701972
Cinnamomum parthenoxylon is a significant essential oil plant in southern China, however, the challenge of rooting cuttings poses a hindrance to its development and widespread cultivation. Adventitious root (AR) formation...
3.
Yu H, Su X, Tao W, Sun W, Zhang X, Han Q, et al.
BMJ Open
. 2024 Dec;
14(12):e087550.
PMID: 39672583
Objectives: To describe the prevalence, clinical characteristics and risk factors of liver steatosis and fibrosis in type 2 diabetes mellitus (T2DM) patients in eastern China. Design: A cross-sectional, multicentre study...
4.
Zhou W, Yan T, Hu Z, Wu J, Zhou Y, Xie L, et al.
J Cancer
. 2024 Dec;
15(20):6698-6709.
PMID: 39668823
Immune cells are crucial components of the immune system and significantly influence tumor progression. However, their direct involvement in lung adenocarcinoma (LUAD) and the potential mediation by plasma metabolites remain...
5.
Hu S, Guo Q, Ye J, Ma H, Zhang M, Wang Y, et al.
Front Oncol
. 2024 Nov;
14:1427170.
PMID: 39544305
Background: The incidence and mortality rates of cancer are the highest globally. Developing novel methodologies that precisely, safely, and economically differentiate between benign and malignant lung conditions holds immense clinical...
6.
Wang Z, Lv J, Xie D, Li X, Liu X, Li N, et al.
Int J Biol Macromol
. 2024 Nov;
282(Pt 6):137326.
PMID: 39515697
D-Allulose, with its low calorie content and sweetness comparable to sucrose, has gained significant attention from researchers as an ideal substitute for sucrose. Here, we investigated the effects of D-allulose...
7.
Ren N, Liu X, Luo Y, Li G, Huang Y, Ji D, et al.
Glob Health Res Policy
. 2024 Sep;
9(1):33.
PMID: 39252124
Healthcare-associated infections (HAIs) represent a major global health burden, which necessitate effective frameworks to identify potential risk factors and estimate the corresponding direct economic disease burden. In this article, we...
8.
Lu Y, Zhao X, Yuan M, Zhao M, Liu K, Zhang M, et al.
J Cancer
. 2024 Apr;
15(9):2475-2485.
PMID: 38577600
Chemotherapy resistance is a barrier to effective cancer prognoses. Cisplatin (CDDP) resistance is a major challenge for esophageal cancer (EC) therapy. A deeper understanding of the fundamental mechanisms of cisplatin...
9.
Radiation enteropathy-related depression: A neglectable course of disease by gut bacterial dysbiosis
Liu X, Li Y, Gu M, Xu T, Wang C, Chang P
Cancer Med
. 2024 Mar;
13(4):e6865.
PMID: 38457257
Radiation enteropathy (RE) is common in patients treated with radiotherapy for pelvic-abdominal cancers. Accumulating data indicate that gut commensal bacteria determine intestinal radiosensitivity. Radiotherapy can result in gut bacterial dysbiosis....
10.
Ye F, Li C, Liu F, Liu X, Xu P, Luo R, et al.
Natl Sci Rev
. 2024 Feb;
11(2):nwae030.
PMID: 38333067
Vaccines have been the primary remedy in the global fight against coronavirus disease 2019 (COVID-19). The receptor-binding domain (RBD) of the spike protein, a critical viral immunogen, is affected by...